Dutch Committee Seeks to Expedite MDMA-Assisted Therapy for PTSD

Finance

Reading Time: < 1 minute

Coverage by Oliver Longstaff for Pα+, edited by Josh Hardman. Last month, we learned that the Psychopharmacologic Drugs Advisory Committee (PDAC), convened by the FDA to advise on the potential approval of MDMA-assisted therapy to treat patients with PTSD, had delivered a negative verdict: 10-1 against the notion that the therapeutic benefits outweigh the risks involved.
Source

Source link

Name*
First Last
Email*
Consent*
Yes, I would like to receive future communications from Investly Today.
Comments
This field is for validation purposes and should be left unchanged.

Subscribe to receive the latest business and industry news in your inbox.

Name*
First Last
Email*
Consent*
Yes, I would like to receive future communications from Investly Today.
Email
This field is for validation purposes and should be left unchanged.